QM · rank #15 · 2026-10-20

SNT

GPW · PLN · $765M (USD)

SignalBuy1.6strength 1.6 / 10

verdict · PROCEED

The exact numbers the algorithm saw.

Factor scores and the inputs behind this pick.
Momentum 12-1 Return from 12 months ago to 1 month ago.	+46.11%
ROE TTM Return on equity, trailing 12 months.	+217.6%
Profit margin Net profit margin, trailing 12 months.	+44.8%
Market cap (USD) Size filter: > $300M required (USD-equivalent).	$765M
Anchor (recent) Close on 2026-09-18	$352.60
Anchor (far) Close on 2025-09-19	$241.33

The AI research card

Independent qualitative review of each pick before the order is placed. On the rare day the research service is unavailable, the paper book trades on the quant ranking alone and no card appears here.

Summary

Synektik S.A. is a CEE regional distributor and service provider for da Vinci robotic surgery systems, medical equipment, and radiopharmaceuticals.

Rationale

Exceptional ROE (2.18), strong profit margins (44.8%), and 46.1% 12-1 momentum are validated by 52% YoY revenue growth and surging high-margin procedure consumables under an exclusive regional moat.

Material risks

1Over-dependence on Intuitive Surgical for exclusive distribution rights, creating long-term structural risk if the agreement is non-renewed or renegotiated post-December 2031.
2Public healthcare tender timing volatility and revenue lumpiness, evidenced by the order backlog contracting to PLN 43.3 million as of September 2026.

AI verdict council

Each pick is reviewed independently by 3 models before any order. 2 of 3 voted to proceed.

OpenAI

Proceed

Claude

Caution

Gemini

Proceed